Biomerieux Logo

Webinars

Antibiotic Resistance Webinars

The Role of the Laboratory in Antimicrobial Stewardship

Presented by Dr. Richard Van Enk

 

The Use of the Advanced Expert System™ as an Aid in Detecting Antibiotic Resistance

Presented by Dr. Vincent LaBombardi

 

Autoposting Results with the VITEK® 2: Can We Afford Not To?

Presented by Dr. Vincent LaBombardi

 

Infectious Disease Identification and Susceptibility Testing


 VITEK MS Webinars

bioMérieux and ADVANCE Healthcare present:

MALDI-TOF in Today's Clinical Microbiology Lab; Patient Care and Perspective

Presented by:

Omai B Garner, PhD, D(ABMM)
Assistant Clinical Professor
Associate Director, Clinical Microbiology
Department of Pathology and Laboratory Medicine
UCLA David Geffen School of Medicine

This lecture will focus on MALDI-TOF identification of bacteria and yeast in the clinical microbiology laboratory. A special emphasis will be placed on work flow incorporation and patient impact in relation to this newly FDA approved technology.

 

bioMérieux and CAP Today present:

VITEK MS: Changing the Face of Clinical Microbiology

Presented by:

Christine C. Ginocchio, Ph. D., M. T. (ASCP)
Senior Medical Director and Chief, Division of Infectious Disease Diagnostics
Department of Pathology and Laboratory Medicine
Professor, Hofstra University North Shore-LIJ School of Medicine

VITEK® MS MALDI-TOF Mass Spectrometer represents a revolutionary change for microbiology practice. This system offer ease-of-use, very little technical time, no pre-extraction and preparation steps and generates rapid results of extremely high accuracy. As one of the primary investigators of the validation studies that led to the FDA clearance of VITEK MS, Dr. Ginocchio will review in the clinical trial performance data, and present case studies illustrating the value of rapid diagnosis using mass spectrometry. The VITEK MS MALDI-TOF platform provides rapid microbial identification of 1-2 minutes, which will dramatically enhance the value of the lab and patient care when compared to standard TATs:

  • Bacteria: average 24 hr
  • Yeasts: average 48-72 hr; molds: days to weeks
  • AFB: average 1 day (probe) to 4 weeks (biochems)

When combined with rapid AST, VITEK MS generates results in one day. Earlier diagnosis will improve clinical outcomes, reduce morbidity and mortality, lead to better antibiotic selection and stewardship, and allow for more rapid initiation of appropriate infection control measures.

 


 

Videos

My Role Matters Campaign Video - Watch Video >

Animated Antibiotic Awareness Videos - Watch Video >

Downloads

  • Antibiotic Resistance Infographics – Download
  • Antibiotic Stewardship in Hospitals – Download
  • Antimicrobials in Agriculture and the Environment – Download